Get the Stockscreener App
4.87
22.67%
0.90
Lixte Biotechnology Holdings Inc stock is traded at $4.87, with a volume of 292.31K.
It is up +22.67% in the last 24 hours and up +312.71% over the past month.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
See More
Previous Close:
$3.97
Open:
$3.98
24h Volume:
292.31K
Relative Volume:
0.15
Market Cap:
$13.07M
Revenue:
-
Net Income/Loss:
$-4.69M
P/E Ratio:
-2.0901
EPS:
-2.33
Net Cash Flow:
$-3.81M
1W Performance:
+18.49%
1M Performance:
+312.71%
6M Performance:
+97.17%
1Y Performance:
+119.86%
1-Day Range:
$3.8142
$4.88
1-Week Range:
$3.625
$4.88
52-Week Range:
$0.64
$4.88
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Name
Lixte Biotechnology Holdings Inc
Sector
Industry
Phone
310 203 2902
Address
248 ROUTE 25A, EAST SETAUKET
Compare LIXT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
4.87 | 12.02M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Lixte Biotechnology Holdings Inc Stock (LIXT) Latest News
Published on: 2025-08-01 22:26:18 - metal.it
What makes Lixte Biotechnology Holdings Inc. stock price move sharplyLow Capital High Return Stock Plans Reviewed - beatles.ru
What is the risk reward ratio of investing in Lixte Biotechnology Holdings Inc. stockTop Growth Target Finder To Watch Now - jammulinksnews.com
Why Lixte Biotechnology Holdings Inc. stock attracts strong analyst attentionSmart Stock Forecast Using AI Algorithms - Newser
Best data tools to analyze Lixte Biotechnology Holdings Inc. Equity Warrant stockWeekly Setup Summary for Risk Controlled Trades - Newser
Lixte Biotechnology Holdings Inc. Company Revenue and Profit Trends: A Deep DiveIntraday Price Forecast Using Volume Models - Newser
What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock price move sharplyTrade Ideas Based on Fundamental Metrics - Newser
Recovery Setup Building in Lixte Biotechnology Holdings Inc. Experts SayStock Market Entry Timing Signals Revealed - metal.it
Lixte Biotechnology Holdings Inc. At Decision Level — Rebound or ResistanceDaily Stock Market Swing Alerts Highlight Key Movers - metal.it
What to expect from Lixte Biotechnology Holdings Inc. Equity Warrant in the next 30 daysTactical Trade Setup With Entry Optimizer - Newser
Will breakout in Lixte Biotechnology Holdings Inc. Equity Warrant lead to full recoverySwing Trade Entry and Exit Point Analysis - Newser
Visual analytics tools that track Lixte Biotechnology Holdings Inc. Equity Warrant performanceSafe Entry Strategy with High Win Rate - Newser
Why Lixte Biotechnology Holdings Inc. Equity Warrant stock attracts strong analyst attentionEntry Timing Tracker with Alert Accuracy - Newser
What is Lixte Biotechnology Holdings Inc. Equity Warrant company’s growth strategyPost Market Picks With Low Risk - jammulinksnews.com
Using RSI to spot recovery in Lixte Biotechnology Holdings Inc. Equity Warrant Free Alert Feed for Momentum Based Picks - metal.it
Why is Lixte Biotechnology Holdings Inc. Equity Warrant stock attracting strong analyst attentionSwing Trade Report For Consistent Profits - jammulinksnews.com
Lixte Biotechnology Holdings Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWeekly Growth Stock Entry Point Alerts Highlighted - metal.it
Is Lixte Biotechnology Holdings Inc. a growth stock or a value stockBuild a portfolio that outperforms the market - jammulinksnews.com
How strong is Lixte Biotechnology Holdings Inc. company’s balance sheetMaximize your portfolio’s growth potential - jammulinksnews.com
Regression analysis insights on Lixte Biotechnology Holdings Inc. performanceFree Safe Entry Stock Watch Suggestions - Newser
What the charts say about Lixte Biotechnology Holdings Inc. Equity Warrant today Free Real Market Momentum Signal Generator - Newser
What institutional investors are buying Lixte Biotechnology Holdings Inc. Equity Warrant stockFinancial News Outlook For 2025 - jammulinksnews.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock overvalued or undervaluedAchieve consistent profits with proven methods - jammulinksnews.com
Does Lixte Biotechnology Holdings Inc. Equity Warrant stock perform well during market downturnsMaximize your gains with professional insights - jammulinksnews.com
Should I hold or sell Lixte Biotechnology Holdings Inc. Equity Warrant stock in 2025Free Technical Analysis Support - jammulinksnews.com
What is the dividend policy of Lixte Biotechnology Holdings Inc. stockMaximize returns with disciplined trading approaches - jammulinksnews.com
Is Lixte Biotechnology Holdings Inc. stock a good hedge against inflation3x Growth Potential - beatles.ru
What catalysts could drive Lixte Biotechnology Holdings Inc. Equity Warrant stock higher in 2025Discover stocks with explosive growth potential - jammulinksnews.com
Is it the right time to buy Lixte Biotechnology Holdings Inc. Equity Warrant stockBuild a strong portfolio for growth and safety - jammulinksnews.com
New Product Launches: Will They Boost Lixte Biotechnology Holdings Inc. Stock in 2025Watchlist Winner Update - Newser
What analysts say about Lixte Biotechnology Holdings Inc. stock outlookFree Stock Market Beginners Guide - Newser
How does Lixte Biotechnology Holdings Inc. Equity Warrant generate profit in a changing economyUnlock the power of real-time market data - jammulinksnews.com
How Lixte Biotechnology Holdings Inc. stock performs during market volatilityWatchlist Winner Update - Newser
Lixte Biotechnology Holdings Inc Stock (LIXT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):